Keynote proposes digital biomarkers for measuring ageing
In this Milan Longevity Summit 2026 keynote description, Andrea Maier is said to explore digital biomarkers from wearables, smartphones and AI as tools for measuring ageing and supporting healthy ageing. [1]
Automatic summary · not editorially reviewed
The key findings
The description presents a keynote by Andrea Maier on digital biomarkers of ageing at the Milan Longevity Summit 2026. [1]
The description says the keynote covers wearables, smartphones, artificial intelligence and continuous health monitoring. [1]
The description says the keynote examines a shift toward predictive, preventive and precision medicine. [1]
The source at a glance
- Study type / format
- Video description of a conference keynote
- Population / context
- Attendees of a keynote at the Milan Longevity Summit 2026, as described
- Summary based on
- Creator description
- Original publication
- August 8, 2026
Maier's keynote topic: digital biomarkers of ageing
The description presents a keynote by Andrea Maier, Professor of Geroscience at the National University of Singapore, at the Milan Longevity Summit 2026. The stated topic is digital biomarkers of ageing: how digital technologies could change the way ageing is measured. The description frames this as an emerging field with potential, not as established practice.
Supporting source [1]
Wearables, smartphones and AI named as sources
According to the description, the keynote covers wearable devices, smartphones, artificial intelligence and continuous health monitoring. These are said to generate insights into how people age in real time. The description also says the keynote examines how digital biomarkers could detect subtle changes in physical and cognitive function and personalise interventions. These are described aims of the talk, not reported results.
Supporting source [1]
Stated aim: predictive rather than reactive care
The description says the keynote examines a shift from reactive healthcare to predictive, preventive and precision medicine. It also describes Maier's research as bridging clinical geroscience, digital health and translational medicine, with a focus on strategies to extend healthspan and quality of life. The summit is described as bringing together leaders from science, medicine, policy, business, technology and society under a One Health perspective.
Supporting source [1]
How to interpret this
This is only the video description; the video and transcript were not reviewed. All content is attributed to the description and creator. No study design, sample, data or results are reported, so the described potential of digital biomarkers is not evidence of benefit.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Milan Longevity Summit · youtube.com · August 8, 2026